498 results on '"Ghiorzo, Paola"'
Search Results
2. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres
3. Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.
4. Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
5. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
6. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
7. First international workshop of the ATM and cancer risk group (4-5 December 2019)
8. Molecular Assessment in Patients with Melanoma: When and Why?
9. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
10. Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement
11. Genetic telecounseling: evaluation of efficacy and outcomes through the Genetic Counseling Outcome Scale (GCOS) questionnaire in a cohort of patients with a suspected melanoma susceptibility syndrome
12. Special Issue “Molecular Advances in Cancer Genetics 3.0”
13. Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome
14. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
15. The 5′-untranslated region of p16 INK4 a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding
16. The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding.
17. Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer
18. Molecular Assessment in Patients with Melanoma: When and Why?
19. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
20. Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges
21. Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer
22. MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project
23. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
24. Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
25. A Glance at Molecular Advances in Cancer Genetics: A Baffling Puzzle Still to Be Solved
26. Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
27. Identification, genetic testing, and management of hereditary melanoma
28. Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
29. Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
30. A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer
31. NFB-09. Treatment of cardiac fibroma in aPTCH1-mutated Gorlin syndrome with medulloblastoma
32. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
33. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
34. Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
35. The CDKN2A/p16INK4a 5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma
36. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup
37. The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length
38. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation ofOBFC1
39. Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
40. Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions
41. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project
42. Clinical genetic testing for familial melanoma in Italy: A cooperative study
43. First international workshop of the ATM and cancer risk group (4-5 December 2019)
44. Additional file 1 of Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
45. Additional file 2 of Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
46. Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families
47. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
48. CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment
49. Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
50. Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.